Loading data for CLDI — first visit, this takes a few seconds.
Calidi Biotherapeutics In... (CLDI)
NYSE American: CLDI
· リアルタイム株価 · USD
1.27
-0.09 (-6.62%)
終値時点: Aug 18, 2026, 3:58 PM
Calidi Biotherapeutics Inc. (CLDI) Stock Price, Analysis & Data
-6.62% (1D)
CLDIについて
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-40...
セクター Healthcare
IPO日 Nov 1, 2021
従業員数 29
上場取引所 NYSE American
ティッカー CLDI
ウェブサイト https://www.calidibio.com
決算サプライズ
Calidi BiotherapeuticsはNov 13, 2025に四半期決算を発表しました:
